Research & Development

av人人视频超碰在线看超碰最新网站超碰人人碰在线视频网红家居品牌NOME被指抄袭 碰瓷还是打脸


  只是在發現霍去病大軍之後,才一哄而散。   卓姬又翻了一個白眼,卻無話可說。av人人视频超碰在线看   漢家人並不適合放牧,也不會去吃苦放牧。超碰最新网站   他祖宗跟著太祖高皇帝一路打進了秦國的國都……什麼好東西沒有?超碰人人碰在线视频   子長,你為永安侯雲瑯作傳的時候一定要加上一句。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo